Following a period of difficulties, this Indian drugmaker is seeing renewed focus from market participants. The central issue now revolves around whether current market pricing present an attractive opportunity. https://alyshaohln895229.activoblog.com/52291955/consider-the-firm-should-the-opportunity-become-the-time